Article
Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A.
Hepatology (Baltimore, Md.) - 1 Jul 2009
Liu Zhe, Robida John M, Chinnaswamy Sreedhar, Yi Guanghui, Robotham Jason M, Nelson Heather B, Irsigler Andre, Kao C Cheng, Tang Hengli
Abstract excerpt
UNLABELLED: Hepatitis C virus (HCV) infection leads to acute and chronic liver diseases, and new classes of anti-HCV therapeutics are needed. Cyclosporine A (CsA) inhibits HCV replication and CsA derivatives that lack the immunosuppressive function are currently in clinical trials as candidate an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
